JohnPaulFruehaufMD

Clinical Trials

• Disulfiram in Patients With Metastatic Melanoma Start of enrollment: 2002 Jan 01

  Completed

  Phase 1, Phase 2

• Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma Start of enrollment: 2003 Apr 01

  Completed

  Phase 2

• Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer Start of enrollment: 2005 Sep 01

  Completed

  Phase 2

• Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy Start of enrollment: 2006 Sep 01

  Terminated

  Phase 1

• Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate Start of enrollment: 2009 Jan 01

  Withdrawn

  Phase 2

• Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15

  Completed

  Phase 3

• Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma Start of enrollment: 2010 Aug 01

  Completed

  Phase 2

• Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients Start of enrollment: 2010 Dec 01

  Completed

  Phase 2

• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Start of enrollment: 2013 Sep 16

  Active, not recruiting

  Phase 3

• Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer Start of enrollment: 2005 Jan 20

  Terminated

  Phase 2

• Join now to see all